8307 — Medicskin Holdings Income Statement
0.000.00%
- HK$66.65m
- HK$68.18m
- HK$49.14m
- 38
- 29
- 54
- 33
Annual income statement for Medicskin Holdings, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | R2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 48 | 41.7 | 49.1 | 45.5 | 49.1 |
Cost of Revenue | |||||
Gross Profit | 39.2 | 34.4 | 42.1 | 36.7 | 39.4 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 52.5 | 39.9 | 44.3 | 48.5 | 51.8 |
Operating Profit | -4.47 | 1.8 | 4.82 | -2.92 | -2.62 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -5.31 | 1.31 | 4.42 | -3.7 | -3.12 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5.4 | 1.36 | 4.14 | -3.59 | -3.1 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -3.24 | 0.953 | 3.92 | -3.54 | -3.05 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3.24 | 0.953 | 3.92 | -3.54 | -3.05 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.005 | -0 | 0.01 | -0.01 | -0.008 |
Dividends per Share | |||||
Special Dividends per Share |